Genetic testing results indicated no pathogenic or likely pathogenic variants in the coding and surrounding regions of the TSC1 and TSC2 genes, which are linked to tuberous sclerosis and LAM. This evidence concerns the gene TSC1 and lymphangioleiomyomatosis.